Disorders of mood and affect in Parkinson's disease

Handbook of Clinical Neurology

Volumn 83, Issue , 2007, Pages 421-433

  Weintraub, Daniel ^a,b   Stern, Matthew B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649327197     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)83019-3     Document Type: Review

References (119)

1. Aarsland D., Larsen J.P., Cummings J.L., et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. Arch Neurol 56 (1999) 595-601
2. Aarsland D., Larsen J.P., Tandberg E., et al. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 48 (2000) 938-942
3. 3 agonists?. Am J Geriatr Psychiatry 9 (2001) 22-29
4. Alexopolous G.S., Katz I.R., Reynolds III C.F., et al. The expert consensus guideline series: pharmacotherapy of depressive disorders in older patients. Postgraduate Medicine Special Report (2001) 1-86
5. Allain H., Schuck S., and Manduit N. Depression in Parkinson's disease. BMJ 320 (2000) 1287-1288
6. Andersen J., Aabro E., Gulmann N., et al. Anti-depressive treatment in Parkinson's disease: a controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with l-dopa. Acta Neurol Scand 62 (1980) 210-219
7. Anguenot A., Loll P.Y., Neau J.P., et al. Depression and Parkinson's disease: study of a series of 135 Parkinson's patients. Can J Neurol Sci 29 (2002) 139-146
8. Arciniegas D.B., and Topkoff J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin Clin Neuropsychiatry 5 (2000) 290-306
9. Beck A.T., Ward C.H., Mendelson M., et al. An inventory of measuring depression. Arch Gen Psychiatry 4 (1961) 53-63
10. Bejjani B.P., Damier P., Arnulf I., et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 340 (1999) 1476-1480
11. Berg D., Supprian T., Hofmann E., et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic imaging. J Neurol 246 (1999) 1186-1193
12. Berney A., Vingerhoets F., Perrin A., et al. Effect on mood of subthalmic DBS for Parkinson's disease: a consecutive series of 24 patients [comment]. Neurology 59 (2002) 1427-1429
13. Brooks B.R., Thisted R.A., Appel S.H., et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 63 (2004) 1364-1370
14. Brown A.S., and Gershon S. Dopamine and depression. J Neural Transm 91 (1993) 75-109
15. Brown R.G., Maccarthy B., Gotham A., et al. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 18 (1988) 49-55
16. Caap-Ahlgren M., and Dehlin O. Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview of patients living at home. Arch Gerontol Geriatr 32 (2001) 23-33
17. Cannas A., Spissu A., Floris G.L., et al. Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized condition. Neurol Sci 23 Suppl 2 (2002) S67-S68
18. Cantello R., Aguggia M., Gilli M., et al. Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. J Neurol Neurosurg Psychiatry 52 (1989) 724-731
19. Ceravolo R., Nuti A., Piccinni A., et al. Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology 55 (2000) 1216-1218
20. Cole S.A., Woodard J.L., Juncos J.L., et al. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci 8 (1996) 20-25
21. Corrigan M.H., Denahan A.Q., Wright E., et al. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 11 (2000) 58-65
22. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 149 (1992) 443-454
23. D'Ath P., Katona P., Mullan E., et al. Screening, detection and management of depression in elderly primary care attenders. I: the acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract 11 (1994) 260-266
24. Dell'Agnello G., Ceravolo R., Nuti A., et al. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol 24 (2001) 221-227
25. Di Rocco A., Rogers J.D., Brown R., et al. S-adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial. Mov Disord 15 (2000) 1225-1229
26. Dooneief G., Mirabello E., Bell K., et al. An estimate of the incidence of depression in idiopathic Parkinson's Disease. Arch Neurol 49 (1992) 305-307
27. Dragasevic N., Potrebi A., Damjanovi A., et al. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study. Mov Disord 17 (2004) 528-532
28. Duffy J.D. The neural substrates of motivation. Psychiatr Ann 27 (1997) 39-43
29. Ehmann T.S., Beninger R.J., Gawel M.J., et al. Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 2 (1989) 3-9
30. First M.B., Spitzer R.L., Gibbon M., et al. Structured clinical interview for DSM-IV axis I disorders (SCID), Clinician (1996), Version American Psychiatric Press, Washington, DC
31. Fregni F., Santos C.M., Myczkowski M.L., et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 75 (2004) 1171-1174
32. Giladi N., Treves T.A., Paleacu D., et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 107 (2000) 59-71
33. Global Parkinson's Disease Study Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 17 (2002) 60-67
34. Gonera E.G., van't Hof M., Berger H.J.C., et al. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 12 (1997) 871-876
35. Gotham A., Brown R.G., and Marsden C.D. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49 (1986) 381-389
36. Green J., McDonald W.M., Vitek J.L., et al. Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findings. Neurology 58 (2002) 858-865
37. Green R.L. Regulation of affect. Semin Clin Neuropsychiatry 3 (1998) 195-200
38. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
39. Hantz P., Caradoc-Davies G., Caradoc-Davies T., et al. Depression in Parkinson's disease. Am J Psychiatry 151 (1994) 1010-1014
40. Hauser R.A., and Zesiewicz T.A. Sertraline for the treatment of depression in Parkinson's disease. Mov Disord 12 (1997) 756-759
41. Herzog J., Volkmann J., Krack P., et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 18 (2003) 1332-1337
42. Hoogendijk W.J., Sommer I., Tissingh G., et al. Depression in Parkinson's disease: the impact of symptom overlap on prevalence. Psychosomatics 39 (1998) 416-421
43. Houeto J.L., Mesnage V., Mallet L., et al. Behavioral disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 72 (2002) 701-707
44. Hughes T.A., Ross H.F., Musa S., et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 54 (2000) 1596-1602
45. Isella V., Melzi P., Grimaldi M., et al. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord 17 (2002) 366-371
46. Jimenez-Jimenez F.J., Tejeiro J., Martinez-Junquera G., et al. Parkinsonism exacerbated by paroxetine. Neurology 44 (1994) 2406
47. Kalayam B., and Alexopolous G.S. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 56 (1999) 713-718
48. Kostic V.S., Filipovic S.R., Lecic D., et al. Effect of age at onset of frequency of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 57 (1994) 1265-1267
49. Kuhn W., Heye N., Müller T., et al. The motor performance test series in Parkinson's disease is influenced by depression. J Neural Transm 103 (1996) 349-354
50. Kuzis G., Sabe L., Tiberti C., et al. Cognitive functions in major depression and Parkinson disease. Arch Neurol 54 (1997) 982-986
51. Leentjens A.F., Verhey F.R.J., Lousberg R., et al. The validity of the Hamilton and Montgomery-Åsberg Depression Rating Scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry 15 (2000) 644-649
52. Leentjens A.F., Verhey F.R.J., Luijckx G., et al. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 15 (2000) 1221-1224
53. Leentjens A.F., Marinus J., Van Hilten J.J., et al. The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach. J Neuropsychiatry Clin Neurosci 15 (2003) 74-77
54. Leentjens A.F., Vreeling F.W., Luijckx G.J., et al. SSRIs in the treatment of depression in Parkinson's disease. Int J Geriatr Psychiatry 18 (2003) 552-554
55. Lindenbaum J., Healton E.B., Savage D.G., et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318 (1988) 1720-1728
56. Liu C.Y., Wang S.J., Fuh J.L., et al. The correlation of depression with functional activity in Parkinson's disease. J Neurol 244 (1997) 493-498
57. Lou J., Kearns G., Oken B., et al. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 16 (2001) 190-196
58. Marder K., Tang M., Cote L., et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 52 (1995) 695-701
59. Maricle R.A., Nutt J.G., Valentine R.J., et al. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology 45 (1995) 1757-1760
60. Marin R.S., Fogel B.S., Hawkins J., et al. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 7 (1995) 23-30
61. Marsh L., Williams J.R., Rocco M., et al. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 63 (2004) 293-300
62. Mayberg H.S., Starkstein S.E., Sadzot B., et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 28 (1990) 57-64
63. Mayeux R., Stern Y., Sano M., et al. The relationship of serotonin to depression in Parkinson's disease. Mov Disord 3 (1998) 237-244
64. Mentis M.J., McIntosh A.R., Perrine K., et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 159 (2002) 746-754
65. Menza M.A., and Mark M.H. Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci 6 (1994) 165-169
66. Menza M.A., Palermo B., et al. Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter. J Geriatr Psychiatry Neurol 12 (1999) 49-52
67. Menza M.A., Robertson-Hoffman D.E., and Bonapace A.S. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 34 (1993) 465-470
68. Menza M.A., Sage J., Marshall E., et al. Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord 5 (1990) 148-151
69. Moellentine C., Rummans T., Ahlskog J.E., et al. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 10 (1998) 187-193
70. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
71. Mössner R., Henneberg A., Schmitt A., et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 6 (2001) 350-352
72. Murai T., Muller U., Werheid K., et al. In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 222-228
73. Myslobodsky M., Lalonde F.M., and Hicks L. Are patients with Parkinson's disease suicidal?. J Geriatr Psychiatry Neurol 14 (2001) 120-124
74. Norman S., Tröster A.I., Fields J.A., et al. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsychiatry Clin Neurosci 14 (2002) 31-36
75. O'Suilleabhain P.E., Sung V., Hernandez C., et al. Elevated homocysteine plasma level in patients with Parkinson disease: mood, affective, and cognitive associations. Arch Neurol 61 (2004) 865-868
76. Okun M.S., Walter B.L., McDonald W.M., et al. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol 59 (2002) 1750-1753
77. Olin J.T., Schneider L.S., Katz I.R., et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry 10 (2002) 125-128
78. Olson E.J., Boeve B.F., Silber M.H., et al. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123 (2000) 331-339
79. Parkinson J. An Essay on the Shaking Palsy (1817), Sherwood, Neely and Jones, London
80. Pitcairn T.K., Clemie S., Gray J.M., et al. Impressions of parkinsonian patients from their recorded voices. Br J Disord Commun 25 (1990) 85-92
81. Pluck G.C., and Brown R.G. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 73 (2002) 636-642
82. Racette B.A., Hartlein J.M., Hershey T., et al. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 14 (2002) 438-442
83. Rampello L., Chiechio S., Raffaele R., et al. The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with l-dopa. Clin Neuropharmacol 25 (2002) 21-24
84. Rektorova I., Rektor I., Bares M., et al. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol 10 (2003) 399-406
85. Richard I.H., Schiffer R.B., and Kurlan R. Anxiety and Parkinson's disease. J Neuropsychiatry Clin Neurosci 8 (1996) 383-392
86. Richard I.H., and Kurlan R. Parkinson Study Group. A survey of antidepressant drug use in Parkinson's disease. Neurology 49 (1997) 1168-1170
87. Richard I.H., Kurlan R., Tanner C., et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Neurology 48 (1997) 1070-1077
88. Richard I.H., Justus A.W., and Kurlan R. Relationship between mood and motor fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 35-41
89. Rojo A., Aguilar M., Garolera M.T., et al. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord 10 (2003) 23-28
90. Sano M., Stern Y., Williams J., et al. Coexisting dementia and depression in Parkinson's disease. Arch Neurol 46 (1989) 1284-1286
91. Schenck C.H., Bundlie S.R., and Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46 (1996) 388-393
92. Schiffer R., and Pope L.E. Review of pseudobulbar affect including a novel and new potential therapy. J Neuropsychiatry Clin Neurosci 17 (2005) 447-454
93. Schrag A., Jahanshahi M., and Quinn N. What contributes to quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 69 (2000) 308-312
94. Schuurman A.G., van den Akker M., Ensinck K.T.J.L., et al. Increased risk of Parkinson's disease after depression. Neurology 58 (2002) 1501-1504
95. Sheikh J.I., and Yesavage J.A. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink T.L. (Ed). Clinical Gerontology: a Guide to Assessment and Intervention (1986), The Haworth Press, New York 165-173
96. Shiba M., Bower J.H., Maraganore D.M., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 15 (2000) 669-677
97. Shulman L.M. Apathy in patients with Parkinson's disease. Int Rev Psychiatry 12 (2000) 298-306
98. Shulman L.M., Taback R.L., Rabinstein A.A., et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8 (2002) 193-197
99. Slaughter J.R., Slaughter K.A., Nichols D., et al. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 187-196
100. Starkstein S.E., Mayberg H.S., Leiguarda R., et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 55 (1992) 377-382
101. Starkstein S.E., Mayberg H.S., Preziosi T.J., et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 4 (1992) 134-139
102. Starkstein S.E., Petracca G., Chemerinski E., et al. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord 13 (1998) 29-33
103. Starkstein S.E., Preziosi T.J., Bolduc P.L., et al. Depression in Parkinson's disease. J Nerv Ment Dis 178 (1990) 27-31
104. Starkstein S.E., Preziosi T.J., Forrester A.W., et al. Specificity of affective and autonomic symptoms of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 53 (1990) 869-873
105. Stern Y., Marder K., Tang M., et al. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 43 (1993) 1690-1692
106. Tandberg E., Larsen J.P., Aarsland D., et al. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 53 (1996) 175-179
107. Tandberg E., Larsen J.P., Aarsland D., et al. Risk factors for depression in Parkinson disease. Arch Neurol 54 (1997) 625-630
108. Tandeter H.B., and Shvartzman P. Parkinson's disease camouflaging early signs of hypothyroidism [comment]. Postgrad Med 94 (1993) 187-190
109. Tesei S., Antonini A., Canesi M., et al. Tolerability of paroxetine in Parkinson's disease: a prospective study. Mov Disord 15 (2000) 986-989
110. Tröster A.I., Stalp L.D., Paolo A.M., et al. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol 52 (1995) 1164-1169
111. van de Vijver D.A., Roos R.A., Jansen P.A., et al. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol 54 (2003) 168-170
112. Walsh K., and Bennett G. Parkinson's disease and anxiety. Postgrad Med J 77 (2001) 89-93
113. Weintraub D., Moberg P.J., Duda J.E., et al. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 16 (2003) 178-183
114. Weintraub D., Moberg P.J., Duda J.E., et al. Effect of psychiatric and other non-motor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 52 (2004) 784-788
115. Weintraub D., Morales K.H., Moberg P.J., et al. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord 20 9 (2005) 1161-1169
116. Weintraub D., Newberg A.B., Cary M.S., et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 46 (2005) 227-232
117. Wermuth L., Sørensen P.S., Timm S., et al. Depression in idiopathic Parkinson's disease treated with citalopram: a placebo-controlled trial. Nord J Psychiatry 52 (1998) 163-169
118. Wertman E., Speedie L., Shemesh Z., et al. Cognitive disturbances in Parkinsonian patients with depression. J Neuropsychiatry Neuropsychol Behav Neurol 6 (1993) 31-37
119. Yesavage J.A., Brink T.L., Rose T.L., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17 (1983) 37-49